dacarbazine and pi103

dacarbazine has been researched along with pi103 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Debatin, KM; Halatsch, ME; Karpel-Massle, G; Karpel-Massler, G; Nonnenmacher, L; Schneele, L; Schneider, M; Siegelin, MD; Ströbele, S; Westhoff, MA; Zhou, S1
Agliano, A; Al-Saffar, NMS; Balarajah, G; Clarke, PA; Jackson, LE; Jones, C; Leach, MO; Marshall, LV; Pearson, ADJ; Sidhu, J; Workman, P1

Other Studies

2 other study(ies) available for dacarbazine and pi103

ArticleYear
A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy.
    PloS one, 2015, Volume: 10, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dacarbazine; Drug Synergism; Furans; Glioblastoma; Humans; Neoplasm Staging; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Signal Transduction; Temozolomide; TOR Serine-Threonine Kinases

2015
In vitro nuclear magnetic resonance spectroscopy metabolic biomarkers for the combination of temozolomide with PI3K inhibition in paediatric glioblastoma cells.
    PloS one, 2017, Volume: 12, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Child; Dacarbazine; Furans; Glioblastoma; Humans; Lactic Acid; Phosphorylcholine; Proton Magnetic Resonance Spectroscopy; Pyridines; Pyrimidines; Temozolomide; Treatment Outcome

2017